BioPharma Pharma QC
GC Biopharma Receives WHO Pre-Qualification for BARYCELA
WHO prequalification decision has made BARYCELA now eligible for procurement by the United Nations agencies, including the Pan American Health Organization...
February 20, 2023 | News
Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity
The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, a...
February 17, 2023 | News
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea
This plant is the largest filling and finish facility based in South Korea, established in 2019. GC Biopharma installed an isolator facilities and app...
February 09, 2023 | News
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...
February 03, 2023 | News
Bionomics Released Quarterly Activities and Cashflow Report
Released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 31 December 2022 (Quarter) and up to the date of this annou...
January 31, 2023 | News
Lecanemab Receives Priority Review Status in Japan
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Chri...
January 30, 2023 | News
Alpha Biopharma Submits New Drug Application for Zorifertinib
Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA...
January 30, 2023 | News
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane
First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...
January 26, 2023 | News
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...
January 23, 2023 | News
Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...
January 23, 2023 | News
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC
World's first anti-PD-1 mAb for the first-line treatment of SCLC Making a new record with the median OS of 15.8 months in an international, mult...
January 18, 2023 | News
6 Must-Haves for a Quality Management System
Choose the best one for your business by learning about the 6 essentials that an eQMS needs to be effective. If an eQMS doesn't check the...
January 18, 2023 | News
FDA Accepts GMP Plasmid DMF of OBiO Technology
OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development a...
January 17, 2023 | News
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
Agilent Technologies Inc. (NYSE: A) announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nuclei...
January 13, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
